Literature DB >> 22794213

Sexual dimorphism in periapical inflammation and bone loss from mitogen-activated protein kinase phosphatase-1 deficient mice.

Justin McAbee1, Qiyan Li, Hong Yu, Keith L Kirkwood.   

Abstract

INTRODUCTION: Mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) has been shown to be a key negative regulator of the MAPK pathways of the innate immune system. The impact of MKP-1 in an endodontic model has yet to be studied. Thus, the purpose of this study was to determine the role of MKP-1 in a bacterial-driven model of pathologic endodontic bone loss.
METHODS: Pulps were exposed in both lower first molars of 10-week-old mkp-1(+/+) and mkp-1(-/-) mice and left open to the oral environment for either 3 or 8 weeks. At death, mandibles were harvested and scanned by micro-computed tomography (μCT) to determine periapical bone loss. Histopathologic scoring was then performed on the samples to determine the amount of inflammatory infiltrate within the periapical microenvironment.
RESULTS: Significant bone loss and inflammatory infiltrate were found in all experimental groups when compared with control. No statistical difference was found between mkp-1(+/+) and mkp-1(-/-) at either time point with respect to bone loss or inflammatory infiltrate. At 8 weeks, male mkp-1(-/-) mice were found to have significantly more bone loss and inflammatory infiltrate when compared with female mkp-1(-/-) mice. There was also a significant correlation between an increase in bone loss and increase in inflammatory infiltrate.
CONCLUSIONS: A sexual dimorphism exists in the periapical inflammatory process, where male mkp-1(-/-) mice have more inflammation than female mkp-1(-/-) mice. The increase in inflammatory infiltrate correlates to more bone loss in the male mice.
Copyright © 2012 American Association of Endodontists. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22794213      PMCID: PMC3399764          DOI: 10.1016/j.joen.2012.04.016

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  25 in total

1.  Characterization of bone resorptive mediators in active periapical lesions.

Authors:  P Stashenko; C Y Wang
Journal:  Proc Finn Dent Soc       Date:  1992

2.  Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts.

Authors:  K Hirao; H Yumoto; K Takahashi; K Mukai; T Nakanishi; T Matsuo
Journal:  J Dent Res       Date:  2009-08       Impact factor: 6.116

3.  The binding of actin to p38 MAPK and inhibiting its kinase activity in vitro.

Authors:  Kun Yang; Yong Jiang; Jiahuai Han; Jun Gu
Journal:  Sci China C Life Sci       Date:  2003-02

4.  Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.

Authors:  L Hou; H Sasaki; P Stashenko
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Effects of gender on serum biomarkers of systemic inflammation coincident to experimentally-induced periapical lesions.

Authors:  H Zhang; J L Bain; C P Caskey; L C Sandifer; R B Johnson
Journal:  Arch Oral Biol       Date:  2010-10-12       Impact factor: 2.633

6.  Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.

Authors:  H Yu; Q Li; B Herbert; R Zinna; K Martin; C R Junior; K L Kirkwood
Journal:  Gene Ther       Date:  2010-11-11       Impact factor: 5.250

Review 7.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases.

Authors:  D M Owens; S M Keyse
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 8.  Role of mitogen-activated protein kinase kinase 4 in cancer.

Authors:  A J Whitmarsh; R J Davis
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 9.  Regulation of gene transcription by mitogen-activated protein kinase signaling pathways.

Authors:  Alan J Whitmarsh
Journal:  Biochim Biophys Acta       Date:  2006-11-17

10.  Review of osteoimmunology and the host response in endodontic and periodontal lesions.

Authors:  Dana T Graves; Thomas Oates; Gustavo P Garlet
Journal:  J Oral Microbiol       Date:  2011-01-17       Impact factor: 5.474

View more
  7 in total

1.  Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice.

Authors:  Masato Otawa; Ryuichiro Tanoue; Hirofumi Kido; Yoshihiko Sawa; Junro Yamashita
Journal:  J Endod       Date:  2015-01-30       Impact factor: 4.171

Review 2.  Sexual Dimorphism in Immunity to Oral Bacterial Diseases: Intersection of Neutrophil and Osteoclast Pathobiology.

Authors:  M S Valerio; K L Kirkwood
Journal:  J Dent Res       Date:  2018-09-11       Impact factor: 6.116

3.  Estradiol induces osteoprotegerin expression by human dental pulp cells.

Authors:  Jeeranan Manokawinchoke; Patcharee Ritprajak; Thanaphum Osathanon; Prasit Pavasant
Journal:  Odontology       Date:  2014-09-26       Impact factor: 2.634

4.  Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Authors:  J Jin; E R Machado; H Yu; X Zhang; Z Lu; Y Li; M F Lopes-Virella; K L Kirkwood; Y Huang
Journal:  J Dent Res       Date:  2013-12-18       Impact factor: 6.116

5.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

6.  Global Noncoding microRNA Profiling in Mice Infected with Partial Human Mouth Microbes (PAHMM) Using an Ecological Time-Sequential Polybacterial Periodontal Infection (ETSPPI) Model Reveals Sex-Specific Differential microRNA Expression.

Authors:  Chairmandurai Aravindraja; Matteen R Kashef; Krishna Mukesh Vekariya; Ravi K Ghanta; Shama Karanth; Edward K L Chan; Lakshmyya Kesavalu
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

7.  Sex-based differential regulation of bacterial-induced bone resorption.

Authors:  M S Valerio; D S Basilakos; J E Kirkpatrick; M Chavez; J Hathaway-Schrader; B A Herbert; K L Kirkwood
Journal:  J Periodontal Res       Date:  2016-08-11       Impact factor: 4.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.